Pre-order Enquiry
Request Free Sample
Global Sorafenib Market Research Report 2021
SKU ID : QYR-19356076 | Publishing Date : 18-Oct-2021 | No. of pages : 99
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Sorafenib Market Research Report 2021
1 Sorafenib Market Overview1.1 Product Overview and Scope of Sorafenib
1.2 Sorafenib Segment by Type
1.2.1 Global Sorafenib Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Sorafenib Segment by Application
1.3.1 Global Sorafenib Sales Comparison by Application: (2021-2027)
1.3.2 Kidney Cancer
1.3.3 Liver Cancer
1.3.4 Thyroid Cancer
1.3.5 Other
1.4 Global Sorafenib Market Size Estimates and Forecasts
1.4.1 Global Sorafenib Revenue 2016-2027
1.4.2 Global Sorafenib Sales 2016-2027
1.4.3 Sorafenib Market Size by Region: 2016 Versus 2021 Versus 2027
2 Sorafenib Market Competition by Manufacturers
2.1 Global Sorafenib Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sorafenib Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sorafenib Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sorafenib Manufacturing Sites, Area Served, Product Type
2.5 Sorafenib Market Competitive Situation and Trends
2.5.1 Sorafenib Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sorafenib Players Market Share by Revenue
2.5.3 Global Sorafenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sorafenib Retrospective Market Scenario by Region
3.1 Global Sorafenib Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Sorafenib Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Sorafenib Market Facts & Figures by Country
3.3.1 North America Sorafenib Sales by Country
3.3.2 North America Sorafenib Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Sorafenib Market Facts & Figures by Country
3.4.1 Europe Sorafenib Sales by Country
3.4.2 Europe Sorafenib Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sorafenib Market Facts & Figures by Region
3.5.1 Asia Pacific Sorafenib Sales by Region
3.5.2 Asia Pacific Sorafenib Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Sorafenib Market Facts & Figures by Country
3.6.1 Latin America Sorafenib Sales by Country
3.6.2 Latin America Sorafenib Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sorafenib Market Facts & Figures by Country
3.7.1 Middle East and Africa Sorafenib Sales by Country
3.7.2 Middle East and Africa Sorafenib Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Sorafenib Historic Market Analysis by Type
4.1 Global Sorafenib Sales Market Share by Type (2016-2021)
4.2 Global Sorafenib Revenue Market Share by Type (2016-2021)
4.3 Global Sorafenib Price by Type (2016-2021)
5 Global Sorafenib Historic Market Analysis by Application
5.1 Global Sorafenib Sales Market Share by Application (2016-2021)
5.2 Global Sorafenib Revenue Market Share by Application (2016-2021)
5.3 Global Sorafenib Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Sorafenib Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer Sorafenib Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Natco Pharma
6.2.1 Natco Pharma Corporation Information
6.2.2 Natco Pharma Description and Business Overview
6.2.3 Natco Pharma Sorafenib Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Natco Pharma Sorafenib Product Portfolio
6.2.5 Natco Pharma Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Corporation Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Sorafenib Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cipla Sorafenib Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Sorafenib Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Sorafenib Product Portfolio
6.4.5 Mylan Recent Developments/Updates
7 Sorafenib Manufacturing Cost Analysis
7.1 Sorafenib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sorafenib
7.4 Sorafenib Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sorafenib Distributors List
8.3 Sorafenib Customers
9 Sorafenib Market Dynamics
9.1 Sorafenib Industry Trends
9.2 Sorafenib Growth Drivers
9.3 Sorafenib Market Challenges
9.4 Sorafenib Market Restraints
10 Global Market Forecast
10.1 Sorafenib Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sorafenib by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sorafenib by Type (2022-2027)
10.2 Sorafenib Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sorafenib by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sorafenib by Application (2022-2027)
10.3 Sorafenib Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sorafenib by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sorafenib by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Sorafenib Market Research Report 2021
List of TablesTable 1. Global Sorafenib Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sorafenib Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Sorafenib Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sorafenib Covered in This Study
Table 5. Global Sorafenib Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Sorafenib Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Sorafenib Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sorafenib Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sorafenib Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sorafenib Manufacturing Sites and Area Served
Table 11. Manufacturers Sorafenib Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sorafenib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sorafenib as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sorafenib Sales by Region (2016-2021) & (K Units)
Table 16. Global Sorafenib Sales Market Share by Region (2016-2021)
Table 17. Global Sorafenib Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sorafenib Sales by Country (2016-2021) & (K Units)
Table 19. North America Sorafenib Sales Market Share by Country (2016-2021)
Table 20. North America Sorafenib Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sorafenib Revenue Market Share by Country (2016-2021)
Table 22. Europe Sorafenib Sales by Country (2016-2021) & (K Units)
Table 23. Europe Sorafenib Sales Market Share by Country (2016-2021)
Table 24. Europe Sorafenib Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sorafenib Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sorafenib Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Sorafenib Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sorafenib Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sorafenib Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sorafenib Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Sorafenib Sales Market Share by Country (2016-2021)
Table 32. Latin America Sorafenib Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sorafenib Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sorafenib Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Sorafenib Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sorafenib Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sorafenib Revenue Market Share by Country (2016-2021)
Table 38. Global Sorafenib Sales (K Units) by Type (2016-2021)
Table 39. Global Sorafenib Sales Market Share by Type (2016-2021)
Table 40. Global Sorafenib Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sorafenib Revenue Share by Type (2016-2021)
Table 42. Global Sorafenib Price (USD/Unit) by Type (2016-2021)
Table 43. Global Sorafenib Sales (K Units) by Application (2016-2021)
Table 44. Global Sorafenib Sales Market Share by Application (2016-2021)
Table 45. Global Sorafenib Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sorafenib Revenue Share by Application (2016-2021)
Table 47. Global Sorafenib Price (USD/Unit) by Application (2016-2021)
Table 48. Bayer Corporation Information
Table 49. Bayer Description and Business Overview
Table 50. Bayer Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Bayer Sorafenib Product
Table 52. Bayer Recent Developments/Updates
Table 53. Natco Pharma Corporation Information
Table 54. Natco Pharma Description and Business Overview
Table 55. Natco Pharma Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Natco Pharma Sorafenib Product
Table 57. Natco Pharma Recent Developments/Updates
Table 58. Cipla Corporation Information
Table 59. Cipla Description and Business Overview
Table 60. Cipla Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Cipla Sorafenib Product
Table 62. Cipla Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Sorafenib Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Mylan Sorafenib Product
Table 67. Mylan Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sorafenib Distributors List
Table 71. Sorafenib Customers List
Table 72. Sorafenib Market Trends
Table 73. Sorafenib Growth Drivers
Table 74. Sorafenib Market Challenges
Table 75. Sorafenib Market Restraints
Table 76. Global Sorafenib Sales Forecast by Type (2022-2027) & (K Units)
Table 77. Global Sorafenib Sales Market Share Forecast by Type (2022-2027)
Table 78. Global Sorafenib Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 79. Global Sorafenib Revenue Market Share Forecast by Type (2022-2027)
Table 80. Global Sorafenib Sales Forecast by Application (2022-2027) & (K Units)
Table 81. Global Sorafenib Sales Market Share Forecast by Application (2022-2027)
Table 82. Global Sorafenib Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 83. Global Sorafenib Revenue Market Share Forecast by Application (2022-2027)
Table 84. Global Sorafenib Sales Forecast by Region (2022-2027) & (K Units)
Table 85. Global Sorafenib Sales Market Share Forecast by Region (2022-2027)
Table 86. Global Sorafenib Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 87. Global Sorafenib Revenue Market Share Forecast by Region (2022-2027)
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sorafenib
Figure 2. Global Sorafenib Market Share by Type in 2020 & 2027
Figure 3. Patented Drugs Product Picture
Figure 4. Generic Drugs Product Picture
Figure 5. Global Sorafenib Market Share by Application in 2020 & 2027
Figure 6. Kidney Cancer
Figure 7. Liver Cancer
Figure 8. Thyroid Cancer
Figure 9. Other
Figure 10. Global Sorafenib Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sorafenib Market Size 2016-2027 (US$ Million)
Figure 12. Global Sorafenib Sales 2016-2027 (K Units)
Figure 13. Global Sorafenib Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Sorafenib Sales Share by Manufacturers in 2020
Figure 15. Global Sorafenib Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Sorafenib Players: Market Share by Revenue in 2020
Figure 17. Sorafenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Sorafenib Sales Market Share by Region (2016-2021)
Figure 19. Global Sorafenib Sales Market Share by Region in 2020
Figure 20. Global Sorafenib Revenue Market Share by Region (2016-2021)
Figure 21. Global Sorafenib Revenue Market Share by Region in 2020
Figure 22. the United States Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. UK Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Sorafenib Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Sorafenib by Type (2016-2021)
Figure 45. Sales Market Share of Sorafenib by Application (2016-2021)
Figure 46. Sales Market Share of Sorafenib by Application in 2020
Figure 47. Revenue Share of Sorafenib by Application (2016-2021)
Figure 48. Revenue Share of Sorafenib by Application in 2020
Figure 49. Manufacturing Cost Structure of Sorafenib
Figure 50. Manufacturing Process Analysis of Sorafenib
Figure 51. Sorafenib Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Keyplayers in Global Sorafenib Market Research Report 2021
BayerNatco Pharma
Cipla
Mylan
